A next-gen Ozempic falls short in a drug trial — and Novo Nordisk stock plunges 20%
Novo Nordisk (NVO) released mixed clinical-trial results for its potential Ozempic successor on Friday, leaving Wall Street ...
Reuters17d
Novo Nordisk A/S
The Danish crown weakened on Friday, after disappointing results from a late-stage trial of a new weight-loss drug drove a big fall in the shares of Denmark's largest company, Novo Nordisk.
Novo Nordisk, Valo Health expand drug discovery collaboration
Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an expanded agreement to discover and develop novel treatments for obesity, ty ...
Yahoo Finance25d
Ozempic maker Novo Nordisk to boost production through acquisition
The logo of the Danish pharmaceutical company Novo Nordisk on the facade of the new German headquarters. Christian Schultz/dpa Danish pharma company Novo Nordisk, makers of weight-loss drugs ...
Novo Nordisk (0QIU) Gets a Buy from J.P. Morgan
J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...